mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.2 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |